loading page

Barriers to Medication Adherence in Children, Adolescents, and Young Adults Prescribed Anticoagulation
  • +2
  • Kevin Todd,
  • Lori Luchtman-Jones,
  • Anne Blackmore,
  • Carrie Hennessey,
  • Meghan McGrady
Kevin Todd
Children's Hospital of The King's Daughters

Corresponding Author:[email protected]

Author Profile
Lori Luchtman-Jones
Cincinnati Children's Hospital Medical Center
Author Profile
Anne Blackmore
Cincinnati Children's Hospital Medical Center
Author Profile
Carrie Hennessey
Cincinnati Children's Hospital Medical Center
Author Profile
Meghan McGrady
Cincinnati Children's Hospital Medical Center
Author Profile

Abstract

Pediatric and adolescent and young adult (AYA) thromboembolism is treated with anticoagulation. While anticoagulation non-adherence in adults has been linked to increased morbidity and mortality, much is unknown concerning medication adherence in pediatric and AYA populations. The aims of this study were to describe barriers to adherence in anticoagulated pediatric and AYA outpatients and to explore the relationship between barriers and self-reported adherence. Nearly 75% of patients and caregivers reported barriers to anticoagulation adherence, and a greater number of reported barriers was associated with lower adherence (rpb = 0.48, p = .01). Limitations, clinical implications, and future directions are discussed.
02 May 2022Submitted to Pediatric Blood & Cancer
02 May 2022Submission Checks Completed
02 May 2022Assigned to Editor
15 May 2022Reviewer(s) Assigned
16 Jun 2022Review(s) Completed, Editorial Evaluation Pending
20 Jun 2022Editorial Decision: Revise Major
30 Aug 2022Submission Checks Completed
30 Aug 2022Assigned to Editor
30 Aug 20221st Revision Received
03 Sep 2022Reviewer(s) Assigned
06 Oct 2022Review(s) Completed, Editorial Evaluation Pending
09 Oct 2022Editorial Decision: Accept
Feb 2023Published in Pediatric Blood & Cancer volume 70 issue 2. 10.1002/pbc.30076